THE role that temperature-controlled packaging plays in transporting pharmaceuticals has been highlighted in a new white paper from Tower Cold Chain.
Compounded by the demands of the pandemic, the resource provides insight delivered by experts from across the supply chain including senior decision makers from Johnson & Johnson, DHL and LOT Polish Airlines.
Free to download from the Tower website, the white paper – titled ‘Passive v Active in a globally disrupted age’ – collates the findings of a 90-minute webinar organised by Tower in late 2021. Topics include the rapid changes affecting the industry, new challenges arising in delivering vaccines to remote areas, and the considerations that must be made in selecting the optimum container type for the task.
The publication features an assessment of the relative merits of active, passive and hybrid temperature-controlled packaging solutions with insight on their use across the global pharmaceutical supply chain.
“In some circumstances, active methods are ideal. In others, passive is the only sensible choice to de-risk the shipment,” said Kevin Doran, global head of supply chain at Tower Cold Chain. “When it comes to patient care and the effective delivery of critical pharmaceuticals there’s no benefit in being partisan.
“We felt it was vital that decision makers can get a balanced view, which is why this white paper brings together a wide range of voices to survey the whole landscape and identify the scenarios for the best use of each technology. We’re grateful to all of the experts who gave their time and provide such a rich source of insight and information – and we look forward to sharing it with others.”
